FDA Drug Application (021479) for ZELAPAR by VALEANT PHARM INTL

Back to FDA Applications sponsored by VALEANT PHARM INTL

Application Number021479
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
Dosage1.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZELAPAR
Active IngredientSELEGILINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient SELEGILINE HYDROCHLORIDE3


Back to FDA Applications sponsored by VALEANT PHARM INTL